Skip to main content
. Author manuscript; available in PMC: 2022 Aug 20.
Published before final editing as: Brain Res. 2021 Feb 20:147388. doi: 10.1016/j.brainres.2021.147388

Table 1.

Characteristics of the participants

N(%) or mean (SD) PAE (n=41) Control (n=43) p
Age 11.54 (2.35) 11.95 (2.62) 0.45
Gender
 Male 20 (48.8%) 23 (53.5%) 0.67
 Female 21 (51.2%) 20 (46.5%)
Race
 White 18 (43.9%) 42 (97.7%) <0.001
 Black or African American 4 (9.8%) 0 (0 %)
 American Indian/Alaska Native 2 (4.9%) 0 (0%)
 Asian 2 (4.9%) 0 (0 %)
 Native Hawaiian or Other Pacific Islander 1 (2.4%) 0 (0 %)
 More than One Race 14 (34.1%) 1 (2.3%)
FSIQ 92 (14.76) 115 (12.32) <0.001
Alcohol Exposure
 Confirmed 37 (90.2%)
 Suspected 4 (9.8%)
Other Drug Exposure
 None 7 (17.1%)
 Confirmed 21 (51.2%)
 Suspected 13 (31.7%)
Dysmorphic Facial Features
 Lip (score 4 or 5) 10 (24.4%) 3 (7.0%) 0.13
 Philtrum (score 4 or 5) 15 (36.6%) 3 (7.0%) 0.01
 Palpebral Fissure (≤10th percentile) 4 (9.8%) 3 (7.0%) 0.95
 ≥ 2 Facial Features Present 12 (30.0%) 1 (2.3%) 0.001
Growth Deficiency (10thpercentile)
 Height 5 (12.2%) 0 (0.0%) 0.05
 Weight 2 (4.9%) 3 (7.0%) 0.39
Deficient Brain Growth (10thpercentile)
 Occipital-Frontal Circumference (OFC) 4 (9.8%) 0 (0.0%) 0.08
IOM Diagnostic Category
 FAS 2 (4.9%)
 Partial FAS 11 (26.8%)
 ARND 28 (68.3%)

Note: Six participants in the PAE group and 11 participants in the control group did not have available physical exam information. The four participants with suspected alcohol exposure were included for the following reasons: two met criteria for pFAS, one had adoption records indicating maternal alcohol use, and the final participant had a biological sibling with an FASD diagnosis along with record of the biological mother’s alcohol abuse.